The next-generation surgical robotics market continues to expand rapidly, fueled by advancements in precision medicine and the rising adoption of robotic-assisted procedures across global healthcare systems. Valued at $5.03 billion in 2024, this sector reflects the growing integration of innovative technologies that enhance surgical outcomes and efficiency. As hospitals and surgical centers increasingly prioritize minimally invasive techniques, the demand for next-generation surgical robotics has surged, supported by demographic shifts like an aging population and expanded infrastructure in healthcare facilities. This growth trajectory underscores the market's pivotal role in transforming surgical practices worldwide.
The next-generation surgical robotics market has demonstrated robust expansion, with a market size of $5.03 billion recorded in 2024. This figure is anticipated to climb to $6.29 billion in 2025, achieving a compound annual growth rate (CAGR) of 24.9%. Historical drivers include the heightened adoption of minimally invasive surgeries, demand for precise surgical techniques, an increasing elderly population, expanded hospital infrastructure, and greater awareness of robotic-assisted surgery benefits. These factors have collectively propelled the sector's momentum, positioning next-generation surgical robotics as a cornerstone of modern healthcare delivery.
Looking ahead, the market is forecasted to reach $15.12 billion by 2029, maintaining a strong CAGR of 24.5%. This projected surge is attributed to rising investments in healthcare automation, growing needs for outpatient procedures, proliferation of surgical robotics training programs, supportive reimbursement policies, and a focus on precision surgery. Key trends shaping this period encompass the miniaturization of robotic systems for enhanced maneuverability, development of autonomous capabilities to reduce human error, substantial research and development investments, innovations in haptic feedback for better surgeon control, advanced imaging integrations, and progress in cloud-based surgical platforms that enable real-time data sharing and remote collaboration.
A primary catalyst for the next-generation surgical robotics market growth is the escalating demand for minimally invasive surgical procedures. These methods utilize small incisions and specialized instruments to minimize patient trauma, leading to reduced pain, faster recovery periods, and lower complication risks. The appeal lies in their capacity to limit tissue disruption, thereby decreasing infection probabilities, shortening hospital stays, and accelerating return to normal activities.
Next-generation surgical robotics play an indispensable role by providing surgeons with superior accuracy, enhanced visualization, and precise instrument manipulation, which in turn mitigates errors, preserves healthy tissue, and supports expedited healing. For example, data from the British Association of Aesthetic Plastic Surgeons, a UK-based surgical association, revealed that there were approximately 31,057 minimally invasive cosmetic surgeries in the UK in 2022, signifying a considerable 102% increase from the prior year. This trend highlights how the push for less invasive options is fundamentally accelerating the adoption and expansion of next-generation surgical robotics globally.
Prominent players shaping the next-generation surgical robotics landscape include established innovators focused on integrating cutting-edge technologies into surgical workflows. These companies drive market competition through continuous product enhancements and strategic expansions.
Major players in the Next Generation Surgical Robotics Global Market Report 2025 include: • Johnson & Johnson Services Inc. • Medtronic plc • Stryker Corporation • Zimmer Biomet Holdings Inc. • Smith & Nephew plc • Intuitive Surgical Inc. • Accuray Incorporated • Medical Microinstruments Inc. • PROCEPT BioRobotics Corporation • CMR Surgical Ltd.
In the next-generation surgical robotics market, industry leaders are prioritizing the development of advanced orthopedic robotic platforms to deliver superior patient outcomes via minimally invasive approaches. These platforms empower surgeons to execute highly accurate interventions on bones and joints, optimize implant positioning, and perform procedures with reduced invasiveness. For instance, Stryker Corporation, a medical technology company based in the United States, introduced its fourth-generation Mako SmartRobotics system, Mako 4, in March 2025. The system incorporates advanced 3D CT-based planning and the company's latest Q Guidance System to broaden applications for hip, knee, spine, and shoulder procedures. It is specifically designed to help surgeons in both initial and revision surgeries by providing personalized surgical planning, real-time guidance during operations, and improved workflow efficiency. Additionally, it supports challenging cases like robotic hip revision with features such as augment and screw planning, intraoperative screw trajectory guidance, and compatibility with revision implant portfolios.
The next-generation surgical robotics market is comprehensively segmented to reflect its diverse applications and operational components, enabling targeted analysis and strategic insights.
The next generation surgical robotics market covered in this report is segmented
Subsegments:
As the next-generation surgical robotics market advances toward its projected $15.12 billion valuation by 2029, stakeholders stand to benefit from sustained innovations that prioritize precision, accessibility, and efficiency in surgical care. This evolution not only addresses current demands for minimally invasive solutions but also paves the way for broader integration of automation in global healthcare, ultimately improving patient experiences and operational outcomes across diverse regions and applications.
The Business Research Company provides over 12,000+ market research reports covering 27 industries across 60+ geographies. The reports provide the most comprehensive understanding of the market for a period of over 10 years including historic and forecasted market sizing information, market segmentations, market shares and key trends and strategies. We are a leading market research company that excels in customer, market, product and competitor information.
We provide actionable market insights using secondary research, expert interviews, proprietary data and in-house knowledge. The Business Research Company’s 350+ in-house experts in 28 countries maintain 1,500,000 datasets across 27 Industries including services, manufacturing, healthcare, financial services, and technology. We offer targeted intelligence services to enable your strategic decision-making, from choosing your markets to targeting your customers and out-smarting your competitors.
View the full next generation surgical robotics market report:
https://www.thebusinessresearchcompany.com/repo...
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.